TipRanks
Vycor Medical Inc. (VYCO)
OTHER OTC:VYCO
US Market
VYCO
Vycor Medical
RESEARCH TOOLSreports

Vycor Medical (VYCO) Ratios

9 Followers

Vycor Medical Ratios

VYCO's free cash flow for Q2 2026 was $0.82. For the 2026 fiscal year, VYCO's free cash flow was decreased by $ and operating cash flow was $0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.13 0.12 0.15 0.14 0.14
Quick Ratio
 0.09 0.08 0.11 0.09 0.07
Cash Ratio
 0.03 0.02 0.02 0.01 0.01
Solvency Ratio
 <0.01 >-0.01 >-0.01 >-0.01 -0.09
Operating Cash Flow Ratio
 0.01 >-0.01 0.01 <0.01 -0.06
Short-Term Operating Cash Flow Coverage
 0.08 -0.02 0.07 0.04 -0.27
Net Current Asset Value
$ -4.43M$ -4.35M$ -3.99M$ -3.73M$ -3.28M
Leverage Ratios
Debt-to-Assets Ratio
 1.18 1.21 1.06 1.12 1.16
Debt-to-Equity Ratio
 -0.23 -0.25 -0.29 -0.33 -0.34
Debt-to-Capital Ratio
 -0.29 -0.33 -0.40 -0.50 -0.51
Long-Term Debt-to-Capital Ratio
 -0.03 -0.03 -0.04 -0.04 -0.05
Financial Leverage Ratio
 -0.19 -0.20 -0.27 -0.30 -0.29
Debt Service Coverage Ratio
 0.11 0.10 0.07 0.11 -0.27
Interest Coverage Ratio
 0.46 0.33 -0.09 0.39 -3.32
Debt to Market Cap
 0.42 0.24 0.42 0.38 0.34
Interest Debt Per Share
 0.03 0.03 0.04 0.04 0.03
Net Debt to EBITDA
 8.41 9.54 15.72 10.45 -3.89
Profitability Margins
Gross Profit Margin
82.60%80.58%89.50%90.08%88.50%
EBIT Margin
1.87%1.79%-0.21%2.74%-25.14%
EBITDA Margin
5.25%5.18%3.81%6.90%-20.12%
Operating Profit Margin
2.67%1.82%-0.58%2.75%-25.06%
Pretax Profit Margin
-3.12%-3.77%-6.73%-4.32%-32.68%
Net Profit Margin
-3.32%-3.89%-6.75%-4.77%-33.19%
Continuous Operations Profit Margin
-3.12%-3.77%-6.73%-4.32%-32.68%
Net Income Per EBT
106.25%103.19%100.23%110.48%101.55%
EBT Per EBIT
-116.97%-207.05%1169.50%-156.95%130.40%
Return on Assets (ROA)
-7.37%-8.72%-10.74%-7.02%-47.19%
Return on Equity (ROE)
1.44%1.77%2.91%2.10%13.80%
Return on Capital Employed (ROCE)
-1.17%-0.86%0.26%-1.30%10.97%
Return on Invested Capital (ROIC)
-1.46%-1.10%0.35%-1.81%15.74%
Return on Tangible Assets
-7.37%-8.72%-10.74%-8.33%-49.41%
Earnings Yield
-2.68%-1.79%-4.66%-2.77%-14.22%
Efficiency Ratios
Receivables Turnover
 8.93 8.51 6.48 6.79 7.83
Payables Turnover
 2.81 4.27 1.13 1.23 0.70
Inventory Turnover
 1.65 2.27 0.75 0.62 0.57
Fixed Asset Turnover
 13.74 9.85 5.36 3.63 3.64
Asset Turnover
 2.22 2.24 1.59 1.47 1.42
Working Capital Turnover Ratio
 -0.42 -0.46 -0.44 -0.44 -0.42
Cash Conversion Cycle
 132.23 117.98 219.60 346.75 173.34
Days of Sales Outstanding
 40.88 42.88 56.33 53.79 46.62
Days of Inventory Outstanding
 221.06 160.60 486.18 589.60 645.88
Days of Payables Outstanding
 129.71 85.50 322.90 296.64 519.16
Operating Cycle
 261.94 203.48 542.50 643.39 692.50
Cash Flow Ratios
Operating Cash Flow Per Share
 <0.01 >-0.01 <0.01 <0.01 >-0.01
Free Cash Flow Per Share
 <0.01 >-0.01 <0.01 <0.01 >-0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.97 1.39 0.93 0.68 1.01
Dividend Paid and CapEx Coverage Ratio
 0.19 -0.04 0.18 3.14 -78.06
Capital Expenditure Coverage Ratio
 38.29 -2.58 14.32 3.14 -78.06
Operating Cash Flow Coverage Ratio
 0.06 -0.01 0.06 0.03 -0.22
Operating Cash Flow to Sales Ratio
 0.03 >-0.01 0.04 0.02 -0.18
Free Cash Flow Yield
2.67%-0.46%2.43%0.80%-7.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -37.22 -10.17 -21.21 -36.12 -7.03
Price-to-Sales (P/S) Ratio
 1.24 2.17 1.45 1.72 2.33
Price-to-Book (P/B) Ratio
 -0.53 -0.99 -0.62 -0.76 -0.97
Price-to-Free Cash Flow (P/FCF) Ratio
 37.41 -216.00 41.17 125.57 -12.98
Price-to-Operating Cash Flow Ratio
 36.43 -299.76 38.30 85.53 -13.15
Price-to-Earnings Growth (PEG) Ratio
 0.04 -0.04 0.29 6.60 0.25
Price-to-Fair Value
 -0.53 -0.99 -0.62 -0.76 -0.97
Enterprise Value Multiple
 31.97 51.38 53.75 35.44 -15.49
Enterprise Value
 3.03M 4.96M 3.25M 3.57M 3.81M
EV to EBITDA
 31.97 51.38 53.75 35.44 -15.49
EV to Sales
 1.68 2.66 2.05 2.44 3.12
EV to Free Cash Flow
 50.77 -265.29 58.19 178.11 -17.34
EV to Operating Cash Flow
 49.44 -368.16 54.13 121.30 -17.56
Tangible Book Value Per Share
 -0.13 -0.12 -0.11 -0.11 -0.09
Shareholders’ Equity Per Share
 -0.13 -0.12 -0.11 -0.10 -0.09
Tax and Other Ratios
Effective Tax Rate
 >-0.01 0.00 0.00 0.00 0.00
Revenue Per Share
 0.05 0.06 0.05 0.04 0.04
Net Income Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 -0.01
Tax Burden
 1.06 1.03 1.00 1.10 1.02
Interest Burden
 -1.67 -2.10 31.71 -1.58 1.30
Research & Development to Revenue
 0.00 <0.01 <0.01 0.02 0.00
SG&A to Revenue
 0.77 0.78 0.85 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 0.03 0.02 <0.01 0.15
Income Quality
 -1.02 0.19 -0.56 -0.42 0.54
Currency in USD